Gainers
- DBV Technologies (NASDAQ:DBVT) stock increased by 18.7% to $1.9 during Tuesday's after-market session. The company's market cap stands at $356.7 million.
- NeuroOne Medical Tech (NASDAQ:NMTC) stock increased by 11.84% to $1.7. Today's trading volume for this security ended up closing at 57.9K shares, which is 30.7 percent of its average volume over the last 100 days. The company's market cap stands at $27.5 million.
- Universal Health Services (NYSE:UHS) stock rose 11.19% to $107.5. The market value of their outstanding shares is at $7.8 billion. As per the news, the Q3 earnings report came out today.
- Avinger (NASDAQ:AVGR) stock rose 9.25% to $1.18. The company's market cap stands at $8.3 million.
- Ensysce Biosciences (NASDAQ:ENSC) shares increased by 7.96% to $0.23. At the close, Ensysce Biosciences's trading volume reached 1.8 million shares. This is 142.2% of its average volume over the last 100 days. The market value of their outstanding shares is at $8.6 million.
- Inventiva (NASDAQ:IVA) shares rose 7.33% to $6.0. The market value of their outstanding shares is at $252.8 million.
Losers
- Heart Test Laboratories (NASDAQ:HSCS) shares fell 14.3% to $2.13 during Tuesday's after-market session. The market value of their outstanding shares is at $17.4 million.
- Taysha Gene Therapies (NASDAQ:TSHA) shares fell 11.41% to $2.64. Trading volume for this security closed at 12.0 million, accounting for 10698.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $108.4 million.
- Scopus BioPharma (NASDAQ:SCPS) stock decreased by 10.16% to $0.24. The market value of their outstanding shares is at $5.0 million.
- Revelation Biosciences (NASDAQ:REVB) stock decreased by 9.98% to $0.37. Trading volume for this security closed at 3.2 million, accounting for 122.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $8.7 million.
- Omeros (NASDAQ:OMER) shares fell 9.35% to $3.2. The company's market cap stands at $200.7 million.
- Adaptimmune Therapeutics (NASDAQ:ADAP) shares decreased by 7.88% to $1.17. The market value of their outstanding shares is at $191.1 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
